Sucampo Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Sucampo Pharma (SCMP) Misses Q1 EPS by 17c, Reiterates FY Guidance
May 3, 2017 6:37 AM EDTSucampo Pharma (NASDAQ: SCMP) reported Q1 EPS of $0.10, $0.17 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $56.3 million versus the consensus estimate of $54.14 million.
Sucampo today reiterated its guidance for the full year ending December 31, 2017. Sucampo expects total revenue of... More
